Literature DB >> 34160126

The contribution of TFPIα to the hemostatic response to injury in mice.

Tanya T Marar1, Nicholas D Martinez2, Susan A Maroney2, Amy E Siebert2, Jie Wu1, Timothy J Stalker1, Maurizio Tomaiuolo1, Sinny Delacroix3, Robert D Simari4, Alan E Mast2,5, Lawrence F Brass1.   

Abstract

BACKGROUND: Tissue factor pathway inhibitor (TFPI) is an essential regulator of coagulation, limiting thrombin generation and preventing thrombosis. In humans and mice, TFPIα is the sole isoform present in platelets.
OBJECTIVE: Here, we asked whether TFPIα, because of its release from platelets at sites of injury, has a unique role in limiting the hemostatic response.
METHODS: TFPIα-mutant (TfpiΔα/Δα ) mice were generated by introducing a stop codon in the C-terminus. Platelet accumulation, platelet activation, and fibrin accumulation were measured following penetrating injuries in the jugular vein and cremaster muscle arterioles, and imaged by fluorescence and scanning electron microscopy. Time to bleeding cessation was recorded in the jugular vein studies.
RESULTS: TfpiΔα/Δα mice were viable and fertile. Plasma TFPI levels were normal in the TfpiΔα/Δα mice, no TFPI protein or activity was present in their platelets and thrombin-antithrombin complex levels were indistinguishable from Tfpi+/+ littermates. There was a small, but statistically significant reduction in the time to bleeding cessation following jugular vein puncture injury in the TfpiΔα/Δα mice, but no measurable changes in platelet or fibrin accumulation or in hemostatic plug architecture following injury of the micro- or macrovasculature.
CONCLUSION: Loss of TFPIα expression does not produce a global prothrombotic state in mice. Platelet TFPIα is expected to be released or displayed in a focal manner at the site of injury, potentially accumulating to high concentrations in the narrow gaps between platelets. If so, the data from the vascular injury models studied here indicate this is not essential for a normal hemostatic response in mice.
© 2021 International Society on Thrombosis and Haemostasis.

Entities:  

Keywords:  TFPIα; anticoagulant; hemostasis; platelets; tissue factor pathway inhibitor

Mesh:

Substances:

Year:  2021        PMID: 34160126      PMCID: PMC8571650          DOI: 10.1111/jth.15430

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   16.036


  63 in total

1.  TFPIβ is the GPI-anchored TFPI isoform on human endothelial cells and placental microsomes.

Authors:  Thomas J Girard; Elodee Tuley; George J Broze
Journal:  Blood       Date:  2011-12-05       Impact factor: 22.113

Review 2.  Regulation of coagulation by a multivalent Kunitz-type inhibitor.

Authors:  G J Broze; T J Girard; W F Novotny
Journal:  Biochemistry       Date:  1990-08-21       Impact factor: 3.162

3.  Platelet-targeting sensor reveals thrombin gradients within blood clots forming in microfluidic assays and in mouse.

Authors:  J D Welsh; T V Colace; R W Muthard; T J Stalker; L F Brass; S L Diamond
Journal:  J Thromb Haemost       Date:  2012-11       Impact factor: 5.824

4.  Tissue factor pathway inhibitor: the carboxy-terminus is required for optimal inhibition of factor Xa.

Authors:  R Wesselschmidt; K Likert; T Girard; T C Wun; G J Broze
Journal:  Blood       Date:  1992-04-15       Impact factor: 22.113

5.  TFPIbeta, a second product from the mouse tissue factor pathway inhibitor (TFPI) gene.

Authors:  J Y Chang; D M Monroe; J A Oliver; H R Roberts
Journal:  Thromb Haemost       Date:  1999-01       Impact factor: 5.249

6.  Protein S stimulates inhibition of the tissue factor pathway by tissue factor pathway inhibitor.

Authors:  Tilman M Hackeng; Kristin M Seré; Guido Tans; Jan Rosing
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-17       Impact factor: 11.205

7.  Heparin induces release of extrinsic coagulation pathway inhibitor (EPI).

Authors:  P M Sandset; U Abildgaard; M L Larsen
Journal:  Thromb Res       Date:  1988-06-15       Impact factor: 3.944

8.  Tissue factor pathway inhibitor overexpression inhibits hypoxia-induced pulmonary hypertension.

Authors:  Thomas A White; Tyra A Witt; Shuchong Pan; Cheryl S Mueske; Laurel S Kleppe; Eric W Holroyd; Hunter C Champion; Robert D Simari
Journal:  Am J Respir Cell Mol Biol       Date:  2009-07-31       Impact factor: 6.914

9.  A supersulfated low-molecular-weight heparin (IK-SSH) increases plasma levels of free and total tissue factor pathway inhibitor after intravenous and subcutaneous administration in humans.

Authors:  B Kaiser; E Glusa; D A Hoppensteadt; H K Breddin; J Amiral; J Fareed
Journal:  Blood Coagul Fibrinolysis       Date:  1998-09       Impact factor: 1.276

10.  Platelet full length TFPI-α in healthy volunteers is not affected by sex or hormonal use.

Authors:  Kristien Winckers; Stella Thomassen; Hugo Ten Cate; Tilman M Hackeng
Journal:  PLoS One       Date:  2017-02-03       Impact factor: 3.240

View more
  1 in total

1.  TFPI inhibits breast cancer progression by suppressing ERK/p38 MAPK signaling pathway.

Authors:  Mengying Xing; Ying Yang; Jiaxue Huang; Yaqun Fang; Yucui Jin; Lingyun Li; Xiang Chen; Xiaoxia Zhu; Changyan Ma
Journal:  Genes Genomics       Date:  2022-05-14       Impact factor: 2.164

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.